
Passage Bio, Inc.
PASGHealthcare|Biotechnology|US
$3.98
+0.52 (+14.88%)
DCF Value
$6.70
Tangible Book / Share
$1.39
Cash / Share
$7.53
Ownership Breakdown
92.3%
Float
3.2M
Shares Outstanding
3.0M
Float Shares
Major Holders (8)
Combined: 84.9%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | Partnership | 21.00% | 673,759 | Jul 2, 2026 | 13D/G |
| Weston Nichols | Individual | 21.00% | 673,759 | Jul 2, 2026 | 13D/G |
| Orbimed Advisors LLC | Investment adviser | 7.82% | 243,878 | Jul 21, 2025 | 13D/G |
| Orbimed Capital GP VII LLC | Other | 7.82% | 243,878 | Jul 21, 2025 | 13D/G |
| Baselake Management, LLC | IA, OO | 7.30% | 235,058 | Jun 25, 2026 | 13D/G |
| Baselake Partners, LP | Partnership | 7.30% | 235,058 | Jun 25, 2026 | 13D/G |
| David Paolella | HC, IN | 7.30% | 235,058 | Jun 25, 2026 | 13D/G |
| Erste Asset Management GmbH | Non-US institution | 5.40% | 2,960,800 | Nov 14, 2024 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,667,631 acquired · 989,421 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10 percent owner | Jun 25, 2026 | BUY | 50,055 | $4.12 | $206.1K | Form 4 |
| Sondhi Dolan | director | May 19, 2026 | AWARD | 10,539 | $5.08 | $53.5K | Form 4 |
| Porter Derrell | director | May 19, 2026 | AWARD | 10,539 | $5.08 | $53.5K | Form 4 |
| Kassberg Thomas Richard | director | May 19, 2026 | AWARD | 10,539 | $5.08 | $53.5K | Form 4 |
| Kapadia Sandip | director | May 19, 2026 | AWARD | 10,539 | $5.08 | $53.5K | Form 4 |
| GOWEN MAXINE | director | May 19, 2026 | AWARD | 10,539 | $5.08 | $53.5K | Form 4 |
| Countouriotis Athena | director | May 19, 2026 | AWARD | 10,539 | $5.08 | $53.5K | Form 4 |
| Borthwick Kathleen | CFO | Mar 16, 2026 | AWARD | 15,610 | $7.64 | $119.3K | Form 4 |
| Chou William | director, officer: PRESIDENT AND CEO | Mar 16, 2026 | AWARD | 58,000 | $7.64 | $443.1K | Form 4 |
| Chou William | director, officer: PRESIDENT AND CEO | Jan 8, 2026 | OPTION EX. | 10,000 | — | — | Form 4 |
| Chou William | director, officer: PRESIDENT AND CEO | Jan 8, 2026 | OPTION EX. | 10,000 | — | — | Form 4 |
| Chou William | director, officer: PRESIDENT AND CEO | Jan 8, 2026 | SELL | 4,076 | $18.44 | $75.2K | Form 4 |
| Borthwick Kathleen | CFO | Jan 8, 2026 | OPTION EX. | 5,000 | — | — | Form 4 |
| Borthwick Kathleen | CFO | Jan 8, 2026 | SELL | 2,062 | $18.44 | $38.0K | Form 4 |
| Borthwick Kathleen | CFO | Jan 8, 2026 | OPTION EX. | 5,000 | — | — | Form 4 |
| Borthwick Kathleen | CFO | Jan 15, 2025 | AWARD | 10,000 | — | — | Form 4 |
| Chou William | director, officer: PRESIDENT AND CEO | Jan 15, 2025 | AWARD | 20,000 | — | — | Form 4 |
| Lynx1 Capital Management LP | 10 percent owner | Sep 15, 2025 | BUY | 11,900 | $6.99 | $83.2K | Form 4 |
| Lynx1 Capital Management LP | 10 percent owner | Sep 12, 2025 | BUY | 19,783 | $6.99 | $138.3K | Form 4 |
| Lynx1 Capital Management LP | 10 percent owner | Sep 11, 2025 | BUY | 325 | $6.96 | $2.3K | Form 4 |
| Lynx1 Capital Management LP | 10 percent owner | Jul 24, 2025 | BUY | 66,423 | $5.71 | $379.5K | Form 4 |
| Lynx1 Capital Management LP | 10 percent owner | Jul 23, 2025 | BUY | 49,302 | $5.74 | $283.0K | Form 4 |
| Lynx1 Capital Management LP | 10 percent owner | Jul 22, 2025 | BUY | 13,123 | $5.44 | $71.3K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Jun 24, 2025 | SELL | 231,600 | $0.35 | $81.1K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Jun 25, 2025 | SELL | 138,800 | $0.33 | $45.8K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Jun 26, 2025 | SELL | 213,257 | $0.33 | $70.4K | Form 4 |
| Kapadia Sandip | director | May 28, 2025 | AWARD | 201,857 | $0.36 | $72.6K | Form 4 |
| GOWEN MAXINE | director | May 28, 2025 | AWARD | 201,857 | $0.36 | $72.6K | Form 4 |
| Countouriotis Athena | director | May 28, 2025 | AWARD | 201,857 | $0.36 | $72.6K | Form 4 |
| Porter Derrell | director | May 28, 2025 | AWARD | 201,857 | $0.36 | $72.6K | Form 4 |
| Islam Saqib | director | May 28, 2025 | AWARD | 201,857 | $0.36 | $72.6K | Form 4 |
| Sondhi Dolan | director | May 28, 2025 | AWARD | 201,857 | $0.36 | $72.6K | Form 4 |
| Kassberg Thomas Richard | director | May 28, 2025 | AWARD | 143,789 | $0.36 | $51.7K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Apr 22, 2025 | SELL | 78,049 | $0.34 | $26.5K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Apr 23, 2025 | SELL | 89,328 | $0.34 | $30.4K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Apr 24, 2025 | SELL | 68,195 | $0.32 | $21.8K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Apr 15, 2025 | SELL | 10,326 | $0.38 | $3.9K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Apr 16, 2025 | SELL | 61,638 | $0.33 | $20.3K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Apr 17, 2025 | SELL | 77,090 | $0.33 | $25.4K | Form 4 |
| Borthwick Kathleen | CFO | Mar 15, 2025 | AWARD | 278,386 | $0.39 | $107.7K | Form 4 |
| Chou William | director, officer: PRESIDENT AND CEO | Mar 15, 2025 | AWARD | 779,533 | $0.39 | $301.7K | Form 4 |
| Cale Edgar B. | GC & CORPORATE SECRETARY | Mar 15, 2025 | AWARD | 278,386 | $0.39 | $107.7K | Form 4 |
| Borthwick Kathleen | CFO | Feb 10, 2025 | OPTION EX. | 8,000 | — | — | Form 4 |
| Borthwick Kathleen | CFO | Feb 11, 2025 | SELL | 3,183 | $0.53 | $1.7K | Form 4 |
| Borthwick Kathleen | CFO | Feb 10, 2025 | OPTION EX. | 8,000 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Jan 10, 2025 | SELL | 126,209 | $0.66 | $83.3K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Jan 13, 2025 | SELL | 17,986 | $0.64 | $11.5K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Jan 14, 2025 | SELL | 79,024 | $0.60 | $47.4K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Jan 6, 2025 | SELL | 19,481 | $0.77 | $15.0K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Jan 7, 2025 | SELL | 52,536 | $0.71 | $37.3K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Jan 8, 2025 | SELL | 75,007 | $0.68 | $51.0K | Form 4 |
| Lynx1 Capital Management LP | 10 percent owner | Dec 27, 2024 | BUY | 373,645 | $0.65 | $241.0K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Dec 20, 2024 | SELL | 230,321 | $0.60 | $138.2K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Dec 9, 2024 | SELL | 54,181 | $0.84 | $45.5K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Dec 10, 2024 | SELL | 8,015 | $0.80 | $6.4K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Dec 11, 2024 | SELL | 80 | $0.80 | $64.00 | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Dec 4, 2024 | SELL | 76,200 | $0.79 | $60.2K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Dec 6, 2024 | SELL | 20,903 | $0.82 | $17.1K | Form 4 |
| Lynx1 Capital Management LP | 10 percent owner | Nov 27, 2024 | BUY | 29,300 | $0.67 | $19.7K | Form 4 |
| Lynx1 Capital Management LP | 10 percent owner | Nov 26, 2024 | BUY | 167,055 | $0.71 | $118.2K | Form 4 |
| Lynx1 Capital Management LP | 10 percent owner | Nov 25, 2024 | BUY | 259,998 | $0.56 | $146.7K | Form 4 |
| Cale Edgar B. | GC & CORPORATE SECRETARY | Sep 30, 2024 | AWARD | 50,000 | $0.70 | $35.0K | Form 4 |
| Kassberg Thomas Richard | director | Sep 30, 2024 | AWARD | 174,139 | $0.70 | $121.9K | Form 4 |
| Kassberg Thomas Richard | Sep 10, 2024 | OTHER | 0 | — | — | Form 4 | |
| ORBIMED ADVISORS LLC | 10 percent owner | Sep 19, 2024 | SELL | 39,300 | $0.71 | $27.9K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Sep 16, 2024 | SELL | 63,100 | $0.74 | $46.7K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Sep 17, 2024 | SELL | 111,400 | $0.73 | $81.3K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Sep 18, 2024 | SELL | 25,631 | $0.73 | $18.7K | Form 4 |
| Lynx1 Capital Management LP | 10 percent owner | Aug 7, 2024 | OTHER | 0 | — | — | Form 4 |
| Countouriotis Athena | director | May 21, 2024 | AWARD | 47,693 | $1.28 | $61.0K | Form 4 |
| GOWEN MAXINE | director | May 21, 2024 | AWARD | 47,693 | $1.28 | $61.0K | Form 4 |
| Kapadia Sandip | director | May 21, 2024 | AWARD | 47,693 | $1.28 | $61.0K | Form 4 |
| Islam Saqib | director | May 21, 2024 | AWARD | 47,693 | $1.28 | $61.0K | Form 4 |
| Sondhi Dolan | director | May 21, 2024 | AWARD | 39,092 | $1.28 | $50.0K | Form 4 |
| Porter Derrell | director | May 21, 2024 | AWARD | 47,693 | $1.28 | $61.0K | Form 4 |
| Borthwick Kathleen | CFO | Mar 15, 2024 | AWARD | 227,000 | $1.50 | $340.5K | Form 4 |
| Forman Mark S | CHIEF MEDICAL OFFICER | Mar 15, 2024 | AWARD | 203,000 | $1.50 | $304.5K | Form 4 |
| Chou William | director, officer: PRESIDENT AND CEO | Mar 15, 2024 | AWARD | 575,000 | $1.50 | $862.5K | Form 4 |
| Cale Edgar B. | GC & CORPORATE SECRETARY | Mar 15, 2024 | AWARD | 203,000 | $1.50 | $304.5K | Form 4 |
| Borthwick Kathleen | SVP, INTERIM CFO | Feb 10, 2024 | OPTION EX. | 4,000 | — | — | Form 4 |
| Borthwick Kathleen | SVP, INTERIM CFO | Feb 13, 2024 | SELL | 1,470 | $0.97 | $1.4K | Form 4 |
| Borthwick Kathleen | SVP, INTERIM CFO | Feb 10, 2024 | OPTION EX. | 4,000 | — | — | Form 4 |
| Forman Mark S | CHIEF MEDICAL OFFICER | Aug 16, 2021 | AWARD | 130,000 | $10.84 | $1.4M | Form 4 |
| Forman Mark S | CHIEF MEDICAL OFFICER | Feb 10, 2024 | OPTION EX. | 5,000 | — | — | Form 4 |
| Forman Mark S | CHIEF MEDICAL OFFICER | Feb 13, 2024 | SELL | 1,638 | $0.97 | $1.6K | Form 4 |
| Forman Mark S | CHIEF MEDICAL OFFICER | Feb 10, 2022 | AWARD | 25,000 | $4.52 | $113.0K | Form 4 |
| Forman Mark S | CHIEF MEDICAL OFFICER | Feb 10, 2022 | AWARD | 15,000 | — | — | Form 4 |
| Forman Mark S | CHIEF MEDICAL OFFICER | Feb 10, 2024 | OPTION EX. | 5,000 | — | — | Form 4 |
| Forman Mark S | Chief Medical Officer | Dec 31, 2023 | OPTION EX. | 50,000 | — | — | Form 4 |
| Forman Mark S | Chief Medical Officer | Jan 2, 2024 | SELL | 15,813 | $0.91 | $14.4K | Form 4 |
| Forman Mark S | Chief Medical Officer | Dec 31, 2023 | OPTION EX. | 50,000 | — | — | Form 4 |
| Borthwick Kathleen | SVP, Interim CFO | Dec 31, 2023 | OPTION EX. | 30,000 | — | — | Form 4 |
| Borthwick Kathleen | SVP, Interim CFO | Jan 2, 2024 | SELL | 10,672 | $0.91 | $9.7K | Form 4 |
| Borthwick Kathleen | SVP, Interim CFO | Dec 31, 2023 | OPTION EX. | 30,000 | — | — | Form 4 |
| Cale Edgar B. | GC & Corporate Secretary | Dec 31, 2023 | OPTION EX. | 50,000 | — | — | Form 4 |
| Cale Edgar B. | GC & Corporate Secretary | Jan 2, 2024 | SELL | 15,813 | $0.91 | $14.4K | Form 4 |
| Cale Edgar B. | GC & Corporate Secretary | Dec 31, 2023 | OPTION EX. | 50,000 | — | — | Form 4 |
| King Simona | Chief Financial Officer | Jul 28, 2023 | OPTION EX. | 31,250 | — | — | Form 4 |
| King Simona | Chief Financial Officer | Jul 28, 2023 | SELL | 11,453 | $0.88 | $10.1K | Form 4 |
| King Simona | Chief Financial Officer | Jul 28, 2023 | OPTION EX. | 31,250 | — | — | Form 4 |